E. Reddy
Nature Reviews. Cancer · with Dang · 2017
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from E. Reddy's perspective
Ordered by how strongly the researchers E. Reddy trusts endorse each paper. Same corpus, a different order for every researcher.
- Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer (Cell)
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism (Science)
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions (Nature)
- Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? (Nature Reviews. Cancer)
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells (Nature)
- Peptide therapeutics: current status and future directions. (Drug Discovery Today)
- Dragging ras back in the ring. (Cancer Cell)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (Science)
- KRAS and YAP1 converge to regulate EMT and tumor survival (Cell)
- Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy (Nature Medicine)
Their papers
- Drugging the ‘undruggable’ cancer targets (2017) — 753 citations